Nuvectra Corp.
(NASDAQ : NVTR)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
ABMDABIOMED, Inc.
-2.58%416.283.3%$583.12m
MDTMedtronic PLC
-0.59%86.300.6%$412.03m
ISRGIntuitive Surgical, Inc.
-2.17%472.722.4%$411.54m
ALGNAlign Technology, Inc.
-1.97%346.316.3%$343.61m
SYKStryker Corporation
-1.29%169.781.3%$338.19m
BSXBoston Scientific Corporation
-1.29%32.201.1%$319.06m
ABTAbbott Laboratories
-1.89%60.770.8%$307.13m
BDXBecton, Dickinson and Company
-1.51%234.011.1%$277.87m
TMOThermo Fisher Scientific Inc.
-1.52%205.571.0%$254.64m
BAXBaxter International Inc.
-1.29%73.361.7%$236.48m
EWEdwards Lifesciences Corporation
-1.57%150.471.2%$197.37m
COOCooper Companies, Inc.
-1.35%234.042.2%$132.24m
XRAYDENTSPLY International Inc.
-0.61%44.683.0%$132.05m
WATWaters Corporation
-0.95%192.023.4%$131.63m
ZBHZimmer Biomet Holdings, Inc.
-0.81%110.851.7%$104.39m

Company Profile

Nuvectra Corp. engages in the development and commercialization of neurostimulation technology platform for treatment of various disorders through stimulation of tissues associated with the nervous systems. It operates through Nuvectra, and NeuroNexus segments. The Nuvectra segmeng is a neurostimulation company committed to helping physicians improve the lives of people with chronic conditions. The NeuroNexus segment designs, manufacture and markets neural-interface technologies for the neuroscience clinical research market. The company was founded on November 14, 2008 and is headquartered in Plano, TX.